Department of Biochemistry and Biophysics

  1. You are here:
  2. Start
  3. Department of Biochemistry and Biophysics

Recent news

  • Structure of a mitochondrial ATP synthase 2019-11-20 SciLifeLab researchers Alexander Mühleip and Alexey Amunts from Stockholm University solved the structure of a mitochondrial ATP synthase with native lipids.
  • Alexey Amunts has been selected to EMBO Young Investigator Programme 2019-11-13 Stockholm University group leader and Head of the SciLifeLab Research Community Programme Alexey Amunts has been selected as an EMBO Young Investigator. The prestigious four-year programme identifies some of Europe’s promising young researchers and provides academic, practical and financial support to help them realize their potential as world-class researchers.
  • SciLifeLab-South Korea collaboration 2019-11-04 Stockholm University and SciLifeLab Cryo-EM training project travels to South Korea and delivers results through international collaboration.
  • Finding out more about the cell’s energy factories 2019-10-29 New opportunities for the development of drugs against tuberculosis and an increased understanding of how the cell’s energy factory works. These topics are highlighted when Martin Högbom and his research team take a closer look at the energy factories in the bacterium Mycobacterium smegmatis.
  • Ville Kaila to be awarded the Sven and Ebba-Christina Hagberg foundation prize 2019-10-29 The Board of Sven and Ebba-Christina Hagberg's foundation has decided to award Dr Stéphanie Robert at the Swedish University of Agricultural Sciences in Umeå and Dr Ville Kaila at Stockholm University the foundations personal prize and a research grant, for a total of SEK 425,000 each.
  • Eminent research on flu antigens took Robert Daniels back to USA 2019-10-24 Intellectual freedom and the opportunity to start his own research group once lured Robert Daniels to Stockholm University and the Department of Biochemistry and Biophysics. After nine years of eminent academic research, he landed a prestigious job in the US. Still, his focus is the same: to apply basic membrane protein folding principles to modernize and improve the antigens in seasonal influenza vaccines.